Ann: Three Complete Responses in Azer-Cel Phase 1b Trial, page-10

  1. 16,284 Posts.
    lightbulb Created with Sketch. 6185
    Great to see ... coincidence the share price trended up in the week leading up to this release ? lol

    Results like these could see an increase in big pharma interest and of course any funding of the potential  Registrational FDA Phase 2/3 package - IMU doesn't have the funding to complete this on their own.   

    @thenguvi  IMU holders are aware more dollars are required but it is amazing how non holders like yourself go straight to the Capital Raise rhetoric - you seriously can't think great results like these wouldn't attract a license deal from big pharma ?

    GLTAH
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.4¢
Change
-0.001(6.67%)
Mkt cap ! $104.5M
Open High Low Value Volume
1.5¢ 1.5¢ 1.3¢ $255.7K 18.24M

Buyers (Bids)

No. Vol. Price($)
65 18692454 1.3¢
 

Sellers (Offers)

Price($) Vol. No.
1.4¢ 4515891 5
View Market Depth
Last trade - 16.10pm 17/06/2025 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.